• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Accenture plc (Amendment)

    3/30/23 4:12:25 PM ET
    $ACN
    Business Services
    Consumer Discretionary
    Get the next $ACN alert in real time by email
    SC 13D/A 1 sc13da033123.htm SC 13D/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13D
    Under the Securities Exchange Act of 1934

    (Amendment No. 5)
    Duck Creek Technologies, Inc.
    (Name of Issuer)
    Common Stock
    (Title of Class of Securities)
    264120 106
    (CUSIP Number)

    Joel Unruch
    Accenture plc
    1 Grand Canal Square
    Grand Canal Harbour
    Dublin 2, Ireland
    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)
    March 30, 2023
    (Date of Event Which Requires Filing of this Statement)
    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box ☐.
    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




    1
    Names of Reporting Persons

    Accenture plc
    2Check the Appropriate Box if a Member of a Group
     (a) ☒
     (b) ☐
    3
    SEC Use Only
    4
    Source of Funds

    OO (see item 3)
    5
    Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):

    ☐
    6
    Citizenship or Place of Organization

    Ireland
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With:
    7
    Sole Voting Power

    0 (see item 5)
    8
    Shared Voting Power

    0 (see item 5)
    9
    Sole Dispositive Power

    0 (see item 5)
    10
    Shared Dispositive Power

    0 (see item 5)
    11
    Aggregate Amount Beneficially Owned by Each Reporting Person

    0 (see item 5)
    12
    Check if the Aggregate Amount in Row (11) Excludes Certain Shares

    ☐
    13
    Percent of Class Represented by Amount in Row (11)

    0.0% (see item 5)
    14
    Type of Reporting Person

    CO




    This Amendment No. 5 (the “Amendment”) amends and supplements the statement on Schedule 13D (the “Original Schedule 13D”), as amended and supplemented by Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4 (the “Amended Schedule 13D,” and as amended and supplemented by this Amendment, the “Schedule 13D”) related to the Common Stock of the Issuer. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Amended Schedule 13D. This Amendment is being filed for the purpose of reporting the disposition of the securities of the Issuer by Accenture plc (“the Reporting Person”) in connection with the closing of the Merger (as defined below).

    Item 4.    Purpose of Transaction

    This Amendment amends and supplements the disclosure in Item 4 of the Original Schedule 13D and the Amended Schedule 13D by adding the following:

    On March 30, 2023, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the Effective Time, each share of Common Stock (other than shares held by the Issuer, Parent, Merger Sub, or any of their respective wholly-owned subsidiaries and shares owned by stockholders who neither voted in favor of the Merger nor consented thereto in writing and who properly and validly exercised their statutory rights of appraisal) was converted into the right to receive cash in an amount equal to $19.00, without interest. As a result of the Merger, Accenture plc no longer beneficially own any securities of the Issuer.

    Item 5. Interest in Securities of the Issuer

    This Amendment amends and restates Items 5(a)-(e) of the Original Schedule 13D and the Amended Schedule 13D in their entirety as set forth below:

    The information in Item 4 is incorporated herein by reference.

    (a)-(b) Effective March 30, 2023, as a result of the Merger, each share of Common Stock owned by the Reporting Person was converted into the right to receive $19.00 in cash, without interest, pursuant to the Merger Agreement. Accordingly, the Reporting Person no longer beneficially owns any shares of Common Stock of the Issuer.

    (c) The Reporting Person has not entered into any transactions in the Shares during the past sixty days.

    (d) Not applicable.

    (e) The Reporting Person ceased to be the beneficial owner of more than five percent of the Common Stock, effective as of March 30, 2023. The filing of this Amendment constitutes an exit filing.


    1



    Signature
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Date: March 30, 2023ACCENTURE PLC
    /s/ Joel Unruch
    Name:Joel Unruch
    Title:
    General Counsel & Corporate Secretary

     

    2

    Get the next $ACN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACN

    DatePrice TargetRatingAnalyst
    3/17/2025$390.00Neutral → Outperform
    Robert W. Baird
    1/8/2025$425.00Peer Perform → Outperform
    Wolfe Research
    12/6/2024$370.00 → $420.00Neutral → Buy
    Goldman
    10/30/2024$375.00Outperform → Neutral
    Exane BNP Paribas
    9/30/2024$321.00 → $400.00Hold → Buy
    TD Cowen
    9/26/2024$329.00 → $395.00Neutral → Overweight
    Piper Sandler
    7/19/2024$400.00Neutral → Buy
    UBS
    6/26/2024$382.00 → $300.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings